New fda approved weight lose drug
regulators are greenlighting a new weight-loss drug called Contrave, the third in a string of approvals for anti-obesity treatments. In testing, patients without diabetes who used the drug lost 4. If a patient has not lost at least 5 percent of their body fat, the drug should be discontinued. Bupropion is an antidepressant also used to help people quit smoking. The drug is approved for use in adults with a body mass index (BMI) of 30 or greater (obese) or adults with a BMI of 27 or greater (overweight) who have at least one weight-related condition such as high blood pressure (hypertension), type 2 diabetes, or high cholesterol (dyslipidemia). The FDA recommends physicians who prescribe the drug evaluate their patients after 12 weeks to determine if it is working. Qsymia is also available at a higher dose (15 mg phentermine and 92 mg of topiramate extended-release) for select patients. The content on this page is provided for reference purposes only. Naltrexone is used to treat alcohol and narcotic dependence. S. Topiramate is indicated to treat certain types of seizures in people who have epilepsy and to prevent migraine headaches. 1 percent more weight than those who took a placebo. Data show that a fetus exposed to topiramate, a component of Qsymia, in the first trimester of pregnancy has an increased risk of oral clefts (cleft lip with or without cleft palate). U. All patients received lifestyle modification that consisted of a reduced calorie diet and regular physical activity.
The safety and efficacy of Qsymia were evaluated in two randomized, placebo-controlled trials that included approximately 3,700 obese and overweight patients with and without significant weight-related conditions treated for one year. Qsymia must not be used during pregnancy because it can cause harm to a fetus. Females of reproductive potential should have a negative pregnancy test before starting Qsymia and every month while using the drug and should use effective contraception consistently while taking Qsymia. 5 milligrams of phentermine and 46 mg of topiramate extended-release. Additional risks include the possibility of seizures, as well as increased blood pressure and heart rates. , based in La Jolla, California. The agency approved the drug for use in combination with a reduced-calorie diet and exercise. The Food and Drug Administration said Thursday that it is approved for use by people who have a body mass index of 30 or higher, which is the level at which people are considered to be obese. Phentermine is indicated for short-term weight loss in overweight or obese adults who are exercising and eating a reduced calorie diet. Females of reproductive potential must not be pregnant when starting Qsymia therapy or become pregnant while taking Qsymia. This content has not been altered or updated since it was archived. Contrave is a combination of two drugs that are already approved, naltrexone and bupropion. The heart effects created a long road to approval for Contrave. The drug was developed by Orexigen Therapeutics Inc. The drug will have a boxed warning about the risk of suicidal thoughts associated with antidepressants like Bupropion. The recommended daily dose of Qsymia contains 7.
New fda approved weight lose drug video:
brand-new fda approved weight lose drug tags:
New fda approved weight lose drug
Related links: treatment weight loss clinics
[url=http://www.builtlean.com/2012/03/16/whey-protein/]Whey Protein Benefits, Risks,
